HCPCS Level II code C1821 identifies an implantable interspinous process distraction device used to provide focal distraction between adjacent spinous processes, commonly applied in the surgical management of lumbar spinal stenosis and related extension-sensitive spinal disorders. As an HCPCS Level II supply/implant code, C1821 matters nationally because it affects device billing, facility chargemaster mapping, and payer coverage determinations for spinal implantation procedures.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the device, common sites of service (operating room and ambulatory surgical centers), and the types of benchmarks and policy topics typically relevant to implantable device codes—coverage criteria, prior authorization trends, and reimbursement frameworks. The publication highlights how C1821 is used in billing lines for implantable spinal devices and what operational teams should expect when mapping this code in charge capture and claims adjudication.

The analysis addresses policy and billing considerations at a national level, outlines where to expect variability across payers, and summarizes the practical billing elements associated with an implantable interspinous distraction device. Data not available in the input will be noted where applicable.